Healthy Extracts (HYEX) Return on Capital Employed (2016 - 2025)
Healthy Extracts' (HYEX) quarterly Return on Capital Employed came in at 3.73% in Q4 2025, up 2827.0% year-on-year from 0.13% in Q4 2024, and up 43.49% quarter-over-quarter from 6.6% in Q3 2025.
Healthy Extracts (HYEX) Return on Capital Employed (2016 - 2025) Analysis & Trends
Healthy Extracts' Return on Capital Employed history runs 10 years deep, the most recent figure standing at 3.73% for Q4 2025.
- On a quarterly basis, Return on Capital Employed rose 2827.0% year-over-year to 3.73% in Q4 2025; TTM through Dec 2025 was 3.73%, a 2827.0% increase from a year earlier, with the FY2025 full-year figure at 7.04%, up 866.0% from the prior year.
- Return on Capital Employed grew to 3.73% in Q4 2025 per HYEX's latest filing, from 6.6% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 8415.96% in Q3 2023 and bottomed at 559.74% in Q4 2023.
- The 5-year median for Return on Capital Employed is 70.62% (2021), against an average of 492.68%.
- Across the five-year window, Return on Capital Employed tumbled 95729 bps in 2021 and jumped 855684 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 70.62% in 2021, then grew by 9 bps to 64.15% in 2022, then slumped by 773 bps to 559.74% in 2023, then surged by 94 bps to 32.0% in 2024, then surged by 88 bps to 3.73% in 2025.
- Per Business Quant, the three latest HYEX Return on Capital Employed figures stand at 3.73% (Q4 2025), 6.6% (Q3 2025), and 20.3% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 27.36% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -1.50% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.43% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.46% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 20.04% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 5.24% |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | -3.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.73% |
| Sep 30, 2025 | -6.60% |
| Jun 30, 2025 | -20.30% |
| Mar 31, 2025 | -524.49% |
| Dec 31, 2024 | -32.00% |
| Dec 31, 2023 | -559.74% |
| Sep 30, 2023 | 8,415.96% |
| Dec 31, 2022 | -64.15% |
| Sep 30, 2022 | -140.88% |
| Dec 31, 2021 | -70.62% |
| Sep 30, 2021 | -269.17% |
| Jun 30, 2021 | -179.64% |
| Mar 31, 2021 | -139.86% |
| Dec 31, 2020 | -138.41% |
| Sep 30, 2020 | -97.39% |
| Jun 30, 2020 | 548.19% |
| Mar 31, 2020 | 817.43% |
| Dec 31, 2019 | 101.91% |
| Sep 30, 2019 | 48.92% |
| Jun 30, 2019 | 433.58% |